Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P48735: Variant p.Arg140Gly

Isocitrate dehydrogenase [NADP], mitochondrial
Gene: IDH2
Feedback?
Variant information Variant position: help 140 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Arginine (R) to Glycine (G) at position 140 (R140G, p.Arg140Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In D2HGA2. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 140 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 452 The length of the canonical sequence.
Location on the sequence: help EARVEEFKLKKMWKSPNGTI R NILGGTVFREPIICKNIPRL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         EARVEEFKLKKMWKSPNGTIRNILGGTVFREPIICKNIPRL

Mouse                         EARVEEFKLKKMWKSPNGTIRNILGGTVFREPIICKNIPRL

Rat                           EARVEEFKLKKMWKSPNGTIRNILGGTVFREPIICKNIPRL

Bovine                        EARVEEFKLKKMWKSPNGTIRNILGGTVFREPIICKNIPRL

Slime mold                    EARVKEFGLKEMWKSPNGTIRNILDGTVFRGPIICKNLPLL

Baker's yeast                 EARVKEFNLHKMWKSPNGTIRNILGGTVFREPIVIPRIPRL

Fission yeast                 EARVKEYNLKKMWKSPNGTIRNILNGTVFREPILIKNIPKY

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 40 – 452 Isocitrate dehydrogenase [NADP], mitochondrial
Binding site 122 – 122
Binding site 134 – 140
Binding site 149 – 149
Modified residue 155 – 155 N6-acetyllysine
Helix 135 – 143



Literature citations
IDH2 mutations in patients with D-2-hydroxyglutaric aciduria.
Kranendijk M.; Struys E.A.; van Schaftingen E.; Gibson K.M.; Kanhai W.A.; van der Knaap M.S.; Amiel J.; Buist N.R.; Das A.M.; de Klerk J.B.; Feigenbaum A.S.; Grange D.K.; Hofstede F.C.; Holme E.; Kirk E.P.; Korman S.H.; Morava E.; Morris A.; Smeitink J.; Sukhai R.N.; Vallance H.; Jakobs C.; Salomons G.S.;
Science 330:336-336(2010)
Cited for: VARIANTS D2HGA2 GLN-140 AND GLY-140;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.